| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
91,540,000 |
| Market
Cap: |
34.79(M) |
| Last
Volume: |
1,296,467 |
Avg
Vol: |
1,292,882 |
| 52
Week Range: |
$0.38 - $0.9341 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Curis is a biotechnology company focused on the development of therapeutics for the treatment of cancer. Co.'s clinical stage drug candidates are: Emavusertib, which is being tested in a Phase 1/2 dose escalating clinical trial in patients with non-Hodgkin lymphomas; CI-8993, which is a monoclonal antibody; Fimepinostat, which is a small molecule that potently inhibits the activity of histone deacetylase, and phosphotidyl-inositol 3 kinase; CA-170, for which Co. has announced initial data from a clinical study in patients with mesothelioma in conjunction with the Society of lmmunotherapy of Cancer; and CA-327, which is a small molecule antagonist of PDL1 and TIM3.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kaitin Kenneth I |
Director |
– • – |
2017-05-31 |
4 |
D |
$1.71 |
$20,850 |
D/D |
(12,193) |
29,607 |
|
- |
|
| Kaitin Kenneth I |
Director |
– • – |
2017-05-31 |
4 |
OE |
$1.39 |
$20,850 |
D/D |
15,000 |
41,800 |
|
- |
|
| Greenacre Martyn D |
Director |
– • – |
2017-05-31 |
4 |
D |
$1.71 |
$20,850 |
D/D |
(12,193) |
37,945 |
|
- |
|
| Greenacre Martyn D |
Director |
– • – |
2017-05-31 |
4 |
OE |
$1.39 |
$20,850 |
D/D |
15,000 |
50,138 |
|
- |
|
| Mcnab James R |
Director |
– • – |
2017-05-05 |
4 |
AS |
$1.90 |
$30,721 |
I/I |
(16,176) |
50,000 |
|
- |
|
| Mcnab James R |
Director |
– • – |
2017-05-04 |
4 |
AS |
$1.97 |
$59,159 |
I/I |
(30,100) |
66,176 |
|
- |
|
| Mcnab James R |
Director |
– • – |
2017-05-03 |
4 |
AS |
$2.18 |
$65,544 |
I/I |
(30,000) |
96,276 |
|
- |
|
| Mcnab James R |
Director |
– • – |
2017-05-02 |
4 |
AS |
$2.31 |
$82,314 |
I/I |
(35,646) |
126,276 |
|
- |
|
| Mcnab James R |
Director |
– • – |
2017-05-01 |
4 |
AS |
$2.38 |
$90,709 |
I/I |
(38,113) |
161,922 |
|
- |
|
| Mcnab James R |
Director |
– • – |
2017-04-28 |
4 |
AS |
$2.45 |
$105,015 |
I/I |
(42,949) |
200,035 |
|
- |
|
| Mcnab James R |
Director |
– • – |
2017-04-27 |
4 |
AS |
$2.57 |
$95,624 |
I/I |
(37,202) |
242,984 |
|
- |
|
| Mcnab James R |
Director |
– • – |
2017-04-26 |
4 |
AS |
$2.65 |
$52,442 |
I/I |
(19,814) |
280,186 |
|
- |
|
| Mcnab James R |
Director |
– • – |
2017-04-26 |
4 |
AS |
$2.65 |
$86,648 |
D/D |
(32,738) |
879,688 |
|
- |
|
| Mcnab James R |
Director |
– • – |
2017-04-25 |
4 |
AS |
$2.60 |
$148,306 |
D/D |
(56,940) |
912,426 |
|
- |
|
| Mcnab James R |
Director |
– • – |
2017-04-24 |
4/A |
AS |
$2.56 |
$107,862 |
D/D |
(42,076) |
969,366 |
|
- |
|
| Mcnab James R |
Director |
– • – |
2017-04-24 |
4 |
AS |
$2.56 |
$107,862 |
D/D |
(42,076) |
1,269,366 |
|
- |
|
| Mcnab James R |
Director |
– • – |
2017-04-21 |
4/A |
AS |
$2.58 |
$117,841 |
D/D |
(45,705) |
1,011,442 |
|
- |
|
| Mcnab James R |
Director |
– • – |
2017-04-21 |
4 |
AS |
$2.58 |
$117,841 |
D/D |
(45,705) |
1,311,442 |
|
- |
|
| Mcnab James R |
Director |
– • – |
2017-04-20 |
4/A |
AS |
$2.66 |
$59,979 |
D/D |
(22,541) |
1,057,147 |
|
- |
|
| Mcnab James R |
Director |
– • – |
2017-04-20 |
4 |
AS |
$2.66 |
$59,979 |
D/D |
(22,541) |
1,357,147 |
|
- |
|
| Dr. Reddys Holdings Ltd |
10% Owner |
– – • |
2016-09-07 |
4 |
B |
$2.40 |
$24,499,999 |
D/D |
10,208,333 |
27,328,464 |
2.45 |
- |
|
| Greenacre Martyn D |
Director |
– • – |
2016-05-27 |
4 |
S |
$1.69 |
$25,350 |
D/D |
(15,000) |
35,183 |
|
- |
|
| Greenacre Martyn D |
Director |
– • – |
2016-05-27 |
4 |
OE |
$1.67 |
$25,050 |
D/D |
15,000 |
45,183 |
|
- |
|
| Kaitin Kenneth I |
Director |
– • – |
2016-05-26 |
4 |
S |
$1.76 |
$26,400 |
D/D |
(15,000) |
26,800 |
|
- |
|
| Kaitin Kenneth I |
Director |
– • – |
2016-05-26 |
4 |
OE |
$1.67 |
$25,050 |
D/D |
15,000 |
36,800 |
|
- |
|
303 Records found
|
|
Page 2 of 13 |
|
|
